Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:37:57 EDT Sun 12 Oct 2025
Enter Symbol
or Name
USA
CA



Q:FBIO - FORTRESS BIOTECH INC - https://fortressbiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FBIO - Q0.22.51·2.831.82.71-0.09-3.2768.61,9612,0462.81  2.8299  2.704.20  1.32519:47:33Oct 0815 min RT 2¢

Recent Trades - Last 10 of 2046
Time ETExPriceChangeVolume
19:47:33Q2.70-0.10222
19:05:30Q2.6999-0.100125
18:47:30Q2.65-0.15514
18:46:45Q2.69-0.11200
18:30:20Q2.72-0.08300
18:13:24Q2.6517-0.14832,000
17:59:26Q2.73-0.07100
17:48:45Q2.73-0.0737
17:44:57Q2.65-0.1515
17:41:48Q2.68-0.121,500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-10-08 08:31U:FBIONews ReleaseJourney Medical Corporation to Participate in October 2025 Investor Conferences
2025-10-01 08:06U:FBIONews ReleaseFortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $205 Million Series A Financing
2025-10-01 08:01U:FBIONews ReleaseFortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
2025-09-03 08:31U:FBIONews ReleaseJourney Medical Corporation to Participate in September 2025 Investor Conferences
2025-09-02 08:30U:FBIONews ReleaseFortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-18 08:30U:FBIONews ReleaseJourney Medical Corporation to Present at the Emerging Growth Conference
2025-08-14 16:05U:FBIONews ReleaseFortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
2025-08-12 16:01U:FBIONews ReleaseJourney Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
2025-08-07 08:30U:FBIONews ReleaseJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
2025-08-05 16:01U:FBIONews ReleaseJourney Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
2025-07-14 08:30U:FBIONews ReleaseJourney Medical Corporation Announces Expanded Payer Coverage for Emrosi(TM)
2025-07-07 08:31U:FBIONews ReleaseMustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
2025-06-24 08:30U:FBIONews ReleaseJourney Medical to Join Russell 2000(TM) and Russell 3000(TM) Indexes
2025-06-20 08:31U:FBIONews ReleaseJourney Medical Corporation Announces Emrosi(TM) Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
2025-06-09 08:30U:FBIONews ReleaseJourney Medical Corporation Announces Emrosi(TM) Featured on "The Balancing Act" Airing on Lifetime TV
2025-05-30 10:48U:FBIONews ReleaseFortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
2025-05-15 16:05U:FBIONews ReleaseFortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-14 16:02U:FBIONews ReleaseJourney Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-13 16:16U:FBIONews ReleaseCheckpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
2025-05-07 16:01U:FBIONews ReleaseJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025